propane has been researched along with cardiovascular agents in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feil, B; Kalogjera, Z; Petricic, J; Seligmann, O; Wagner, H | 1 |
CHRISTENSEN, HE; DAVIS, H; HINE, CH; MURPHY, FJ; NEAL, MW | 1 |
Braga, VA; França-Silva, MS; Guimarães, DD; Mendes-Júnior, LG; Nalivaiko, E; Queiroz, TM | 1 |
Cao, G; Gu, X; Liu, C; Liu, CZ; Sun, H; Tang, M; Zhang, Q | 1 |
4 other study(ies) available for propane and cardiovascular agents
Article | Year |
---|---|
Phenylpropanes and lignans of Viscum album cardioactive drugs V.
Topics: Cardiovascular Agents; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Glucosides; Humans; Lignans; Mistletoe; Phenylpropionates; Plant Extracts; Plants, Medicinal; Propane | 1986 |
Some pharmacologic comparisons of 1-ethoxy, 3-isopropoxypropane-2-ol and 3,-(2-methylphenoxy) propane-1,2-diol (myanesin).
Topics: Cardiovascular Agents; Mephenesin; Muscle Relaxants, Central; Propane | 1952 |
Cardiorespiratory effects induced by 2-nitrate-1,3-dibuthoxypropan are reduced by nitric oxide scavenger in rats.
Topics: Animals; Arterial Pressure; Bradycardia; Cardiovascular Agents; Consciousness; Dose-Response Relationship, Drug; Heart Rate; Hydroxocobalamin; Hypotension; Male; Nitrates; Nitric Oxide; Nitroglycerin; Propane; Rats; Rats, Wistar; Respiration; Tachypnea; Vasodilator Agents | 2014 |
Employing the Sirolimus-Eluting Poly (Propylene Carbonate) Mesh for the Prevention of Arteriovenous Graft Stenosis in Rats.
Topics: Animals; Aorta, Abdominal; Autografts; Cardiovascular Agents; Cell Movement; Coated Materials, Biocompatible; Equipment Design; Fibroblasts; Graft Occlusion, Vascular; Jugular Veins; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Phosphorylation; Proliferating Cell Nuclear Antigen; Propane; Rats, Wistar; Sirolimus; Surgical Mesh; TOR Serine-Threonine Kinases; Vascular Grafting; Vascular Patency | 2019 |